Related Experiment Videos
Ten-year experience with paediatric lymph node tuberculosis in Port Moresby
P McMaster1, N Ezeilo, H Freisen
1Department of Paediatrics, Port Moresby General Hospital, Papua New Guinea. Paddy_McMaster@compuserve.com
Journal of Tropical Pediatrics
|June 23, 2001
Summary
Short-course chemotherapy for childhood nodal tuberculosis shows promising results, with low relapse rates observed in a descriptive study at Port Moresby General Hospital. This approach offers effective treatment for pediatric tuberculosis lymph node infections.
Area of Science:
- Pediatric Infectious Diseases
- Public Health
- Clinical Medicine
Background:
- Nodal tuberculosis is a significant health concern in children.
- Effective and accessible treatment regimens are crucial for managing pediatric TB.
- Short-course chemotherapy has emerged as a standard treatment for various forms of tuberculosis.
Purpose of the Study:
- To describe the outcomes of short-course chemotherapy in children with nodal tuberculosis.
- To evaluate the relapse rates following treatment completion.
- To assess the feasibility and effectiveness of this treatment strategy in a real-world clinical setting.
Main Methods:
- A descriptive study was conducted at Port Moresby General Hospital.
- Data were collected retrospectively (1989-1996) and prospectively (1997).
- Patient cohorts received short-course chemotherapy for lymph node tuberculosis.
Main Results:
- In the retrospective cohort (n=427), 207 children completed treatment, with an 11.6% relapse rate.
- In the prospective cohort (n=179), 97 children completed treatment, with a 10.6% relapse rate during 1-2 years of follow-up.
- Relapse rates were comparable between the retrospective and prospective groups.
Conclusions:
- Short-course chemotherapy is an effective treatment for pediatric nodal tuberculosis.
- The observed relapse rates suggest the regimen's sustained efficacy.
- This study supports the continued use of short-course chemotherapy for childhood TB lymphadenitis.